Silver Lake Advisory’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $437K | Sell |
1,876
-42
| -2% | -$9.7K | 0.16% | 84 |
|
|
2026
Q2 | $407K | Buy |
1,918
+8
| +0.4% | +$1.57K | 0.15% | 84 |
|
|
2026
Q1 | $374K | Sell |
1,910
-41
| -2% | -$7.97K | 0.15% | 86 |
|
|
2025
Q4 | $339K | Buy |
1,951
+8
| +0.4% | +$1.46K | 0.13% | 85 |
|
|
2025
Q3 | $370K | Buy |
1,943
+9
| +0.5% | +$1.6K | 0.15% | 81 |
|
|
2025
Q2 | $347K | Buy |
1,934
+10
| +0.5% | +$1.74K | 0.15% | 83 |
|
|
2025
Q1 | $326K | Buy |
1,924
+9
| +0.5% | +$1.48K | 0.14% | 88 |
|
|
2024
Q4 | $289K | Sell |
1,915
-30
| -2% | -$4.67K | 0.13% | 87 |
|
|
2024
Q3 | $302K | Buy |
1,945
+10
| +0.5% | +$1.49K | 0.12% | 89 |
|
|
2024
Q2 | $265K | Sell |
1,935
-89
| -4% | -$12.2K | 0.12% | 86 |
|
|
2024
Q1 | $269K | Buy |
+2,024
| New | +$263K | 0.12% | 87 |
|
|
2023
Q3 | – | Sell |
-2,106
| Closed | -$296K | – | 65 |
|
|
2023
Q2 | $296K | Buy |
2,106
+6
| +0.3% | +$827 | 0.16% | 82 |
|
|
2023
Q1 | $297K | Buy |
+2,100
| New | +$300K | 0.17% | 81 |
|
|
2022
Q4 | – | Sell |
-2,090
| Closed | -$256K | – | 68 |
|
|
2022
Q3 | $256K | Buy |
2,090
+5
| +0.2% | +$658 | 0.15% | 85 |
|
|
2022
Q2 | $277K | Buy |
2,085
+10
| +0.5% | +$1.36K | 0.15% | 87 |
|
|
2022
Q1 | $284K | Buy |
2,075
+4
| +0.2% | +$558 | 0.13% | 90 |
|
|
2021
Q4 | $358K | Buy |
2,071
+5
| +0.2% | +$761 | 0.17% | 91 |
|
|
2021
Q3 | $300K | Hold |
2,066
| – | – | 0.15% | 93 |
|
|
2021
Q2 | $300K | Sell |
2,066
-90
| -4% | -$11.8K | 0.14% | 90 |
|
|
2021
Q1 | $277K | Buy |
2,156
+5
| +0.2% | +$616 | 0.14% | 87 |
|
|
2020
Q4 | $256K | Buy |
2,151
+4
| +0.2% | +$488 | 0.14% | 86 |
|
|
2020
Q3 | $246K | Buy |
2,147
+5
| +0.2% | +$591 | 0.15% | 84 |
|
|
2020
Q2 | $244K | Buy |
+2,142
| New | +$227K | 0.16% | 78 |
|
|
2020
Q1 | – | Sell |
-2,142
| Closed | -$229K | – | 82 |
|
|
2019
Q4 | $229K | Hold |
2,142
| – | – | 0.14% | 77 |
|
|
2019
Q3 | $229K | Hold |
2,142
| – | – | 0.15% | 76 |
|
|
2019
Q2 | $218K | Buy |
+2,142
| New | +$206K | 0.14% | 79 |
|
|
2018
Q4 | – | Sell |
-2,142
| Closed | -$231K | – | 85 |
|
|
2018
Q3 | $231K | Hold |
2,142
| – | – | 0.14% | 88 |
|
|
2018
Q2 | $238K | Hold |
2,142
| – | – | 0.19% | 69 |
|
|
2018
Q1 | $215K | Hold |
2,142
| – | – | 0.16% | 82 |
|
|
2017
Q4 | $211K | Hold |
2,142
| – | – | 0.15% | 84 |
|
|
2017
Q3 | $201K | Hold |
2,142
| – | – | 0.15% | 83 |
|
|
2017
Q2 | $238K | Hold |
2,142
| – | – | 0.18% | 75 |
|
|
2017
Q1 | $210K | Buy |
+2,142
| New | +$204K | 0.16% | 78 |
|
Other funds holding DGX
Silver Lake Advisory's DGX Position: Q3 2026 in Review
Silver Lake Advisory reduced its Quest Diagnostics (DGX) stake by 2.2% in Q3 2026, selling an estimated $9.7K and leaving 1,876 shares worth $437K. The position accounts for 0.16% of the portfolio, ranked #84.
Silver Lake Advisory first reported a position in DGX in Q1 2017 and has held it in 33 quarters since. 605 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Silver Lake Advisory held 1,876 shares of Quest Diagnostics worth $437K as of Q3 2026.
- Silver Lake Advisory sold 42 Quest Diagnostics shares in Q3 2026, an estimated $9.7K.
- Quest Diagnostics made up 0.16% of Silver Lake Advisory's portfolio in Q3 2026, its #84 holding.
- Silver Lake Advisory first reported a position in Quest Diagnostics in Q1 2017 and has held it in 33 quarters since.
- 605 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Silver Lake Advisory's 13F filing for Q3 2026, filed 22 Oct 2026.